$STZ

Constellation Brands Non-GAAP EPS of $3.74 beats by $0.19, revenue of $2.63B beats by $90M (STZ:NYSE)

Constellation Brands (STZ) reported Q2 Non-GAAP EPS of $3.74, beating estimates by $0.19. Revenue was $2.63B, up 6.0% year-over-year, exceeding expectations by $90M. The results highlight the company's strong performance in the quarter.

Original reporting
Published Oct 6, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Bullish
high confidence
Mentioned
$STZ
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$STZBullishHigh
01

Why it matters

The beat may trigger short‑term buying interest and could influence peer valuations.

02

Market read

First‑report earnings beat for a large‑cap consumer staple, likely to move the stock and sector.

03

What to watch

Potential headwinds from higher input costs or slower volume growth not discussed.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Constellation Brands is a leading beverage alcohol company; its earnings release is closely watched by investors.

Company-level read

Ticker impact

$STZBullishHigh confidence
Context

Constellation Brands reported Q2 Non‑GAAP EPS of $3.74, beating expectations by $0.19 and revenue of $2.63 B, up $90 M.

Expected impact

upward pressure as the market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded estimates, indicating stronger performance than anticipated.

Market effects

Consumer staples may see modest rally on strong earnings from a major player.

U.S. market may experience a slight lift in beverage and alcohol stocks.

Limited to U.S. equities; no immediate global macro effect.

Counterpoint

If the beat is already priced in, the stock could face profit‑taking pressure.

Key entities

  • Constellation Brands

    Producer of beer, wine, and spirits.

Related articles

$STZHigh

STZ Stock Falls As Modelo And Corona Lose Volume, Full-Year Profit Outlook Holds

Constellation Brands (STZ) reaffirmed its fiscal 2027 earnings guidance of $11.20 to $11.90 per share, with organic net sales and beer net sales expected to range from -1% to +1%. The company also announced the acquisition of SpikedAde for $75 million, with potential earnouts up to $278 million. STZ stock has fallen 16% year-to-date, despite positive retail sentiment on Stocktwits.

$STZMedAI 8/10

Constellation Brands (STZ) Q2 Beats Estimates but Full-Year EPS

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. The company lowered full-year EPS guidance to $11.20-$11.90, below market expectations. STZ offers a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year growth. GuruFocus rates STZ undervalued with a GF Score of 59/100, noting strong profitability but weak momentum. Institutional investors show cautious sentiment.

$STZMedAI 8/10

Constellation Brands buys RTD start-up SpikedAde

Constellation Brands acquired a 100% stake in SpikedAde, a vodka-based RTD brand, for $75m, with up to $278m in performance-based payments. SpikedAde, founded in 2024, has a presence in the eastern US. Constellation plans to expand its distribution using its marketing and sales capabilities.